Guest guest Posted December 23, 2011 Report Share Posted December 23, 2011 GSK welcomes GAVI Alliance decision to introduce vaccines against cervical cancer and rubella in the world's poorest countries GlaxoKline, 11/18/2011GlaxoKline welcomed the decision of the GAVI Board to provide funding to facilitate the provision of cervical cancer immunisation programmes and rubella vaccination, across the world's poorest countries. GAVI has confirmed that it will open a new funding window for vaccines that target the HumanRead more: http://www.mdlinx.com/pharma-news/news-article.cfm/3838136/#ixzz1hO1a1YyM Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.